**(Formerly Gujchem Distillers India Limited)** ZR2 Bioenergy Limited is an Indian listed entity currently executing a high-stakes strategic pivot. Following a change in control on **December 31, 2024**, the company has transitioned from its legacy chemical roots and recent IT trading activities into a dedicated vehicle for **Bio-energy**, **Renewable Infrastructure**, and the **Waste-to-Energy** economy. Under the leadership of **Mr. Jimmy Olsson** (Chairman & Managing Director), the company is positioning itself to capitalize on India’s ethanol blending mandates and the global shift toward decarbonization. --- ### Strategic Transformation & Ownership Structure The company’s trajectory was fundamentally altered by the entry of **ZR2 Group Holdings Limited**, which acquired a **61%** controlling stake to become the new promoter. This acquisition triggered a comprehensive overhaul of the company’s **Memorandum of Association (MoA)**, shifting the corporate mandate toward sustainable energy. **Key Corporate Milestones:** * **Name Change:** Rebranded from Gujchem Distillers India Limited to **ZR2 Bioenergy Limited** to reflect the new core mission. * **Headquarters Relocation:** Shifting the registered office from **Gujarat** to **Mumbai, Maharashtra**, to align with India’s financial hub and improve administrative efficiency. * **Subsidiary Expansion:** * **ZR2 Solar Private Limited:** A subsidiary (incorporated **October 4, 2024**) focused on the generation and distribution of solar, wind, and hydropower. * **International Footprint:** Approved the formation of a **UAE-based subsidiary** in February 2025 to facilitate global operations. --- ### The Integrated Biorefinery & BOOT Model The cornerstone of ZR2’s growth strategy is the transition from a trading-led model to an integrated producer of biofuels. The company intends to mimic the petroleum refinery model to co-produce high-value biofuels and bioproducts, ensuring cost-competitiveness. **The PVSKL Strategic Partnership:** The company has entered into a **Build-Own-Operate-Transfer (BOOT)** agreement with **Padmashri Dr. Vitthalrao Vikhe Patil Sahakari Sakhar Karkhana Ltd (PVSKL)** in Maharashtra. * **Tenure:** **15 years**, extendable by **14 years** (Total **29 years**). * **Asset Scope:** Includes plants for **Ethanol**, **Biogas**, **Extra Neutral Alcohol (ENA)**, and **RO/MEE** units. * **Capital Investment:** As of March 31, 2025, **₹117.1 Crore** was classified as **Capital Work-in-Progress (CWIP)** related to this partnership. **Product Roadmap:** | Segment | Focus Areas | | :--- | :--- | | **Biofuels** | **Ethanol** (E20/E30 blending), **Gasoline**, **Jet Fuel**, and **Diesel** equivalents. | | **Gaseous Fuels** | **Compressed Bio-Gas (CBG)** and **Green Hydrogen** blending for City Gas Distribution. | | **Bioproducts** | **Bio-potash**, **Plastics**, **Lubricants**, and **Industrial Chemicals** from biomass. | | **Renewable Power** | Generation of **Process Steam**, **Heat**, and **Electricity** via biomass and solar. | --- ### Capital Structure & Fundraising Dynamics To fund the acquisition of biorefinery assets and infrastructure, ZR2 Bioenergy has executed a massive capital infusion, significantly expanding its balance sheet. **Preferential Issue Details (August 2024):** The company launched a preferential issue totaling approximately **₹248.77 Crores**. * **Compulsory Convertible Debentures (CCDs):** **1,23,50,000** units issued at **₹65** (Face Value **₹1** + Premium **₹64**). These were fully converted into equity shares on **February 14, 2026**. * **Convertible Warrants:** **2,59,22,000** warrants issued at **₹65**. As of March 2025, **₹42.12 Crore** (25% upfront) was received, with **₹126.37 Crore** pending infusion upon conversion within 18 months. **Financial Position (Standalone):** | Metric | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | | **Total Revenue** | **₹1.88 Crore** | **₹0.28 Crore** | | **Profit After Tax (PAT)** | **₹38.92 Lacs** | **₹3.58 Lacs** | | **Borrowing Limit** | **₹1,250 Crores** | - | | **Investment Limit** | **₹1,250 Crores** | - | *Note: The company has cleared all legacy liabilities, including **₹22 Crore** in unsecured loans, reporting **zero external debt** as of September 2025.* --- ### Operational Status & Transition Phase While the strategic pivot is underway, the company remains in a transitional "pre-production" phase regarding its bioenergy assets. * **Current Revenue Stream:** Primarily derived from the **trading of IT-related products** (e.g., ESTI Protection, Hygrostat, Rotor Rings) and general commodities. * **Manufacturing Commencement:** Full-scale bioenergy production is targeted for the end of **FY 2025-26**, pending final execution of formal BOOT agreements. * **Human Capital:** The **ZR2 Bioenergy ESOP 2025** has been launched, covering **7,13,770** options (approx. **20%** of issued capital) to attract and retain specialized talent. * **Dividend Policy:** No dividends have been recommended as the Board prioritizes resource conservation for capital-intensive expansion. --- ### Risk Factors & Governance Observations Investors should note several critical risks associated with this transition and recent regulatory observations. **1. Regulatory & Compliance Concerns:** * **Deployment of Funds:** Auditors and Monitoring Agencies have flagged a **variation** in the use of **₹18.50 Crore** in unutilized proceeds, which were placed in a short-term deposit with an NBFC (**Sukhmehar Finance**) rather than low-risk bank FDs. * **Governance Gaps:** The resignation of the Company Secretary in **December 2025** cited unaddressed "compliance irregularities." * **Disclosure Issues:** The company faced scrutiny for failing to disclose the specific mode of deployment for unutilized proceeds in its **May 2024** shareholder notice. **2. Financial & Operational Risks:** * **Going Concern Qualification:** Statutory auditors have maintained an **Emphasis of Matter** regarding the company's ability to continue as a going concern, given that legacy manufacturing operations are closed and new bioenergy operations have not yet commenced. * **Project Approvals:** While in-principle approvals from the Government of Maharashtra were received in **July 2025**, the formal execution of the BOOT agreement is a prerequisite for revenue generation from the biorefinery. * **Public Float:** The company must navigate its capital expansion carefully to maintain the mandatory **25% minimum public shareholding** under **Rule 19A of the SCRR**. **3. Market & Macro Risks:** * **Feedstock Volatility:** The business is sensitive to the pricing of sugarcane and grain. The company plans to mitigate this through long-term procurement agreements. * **Global Headwinds:** Exposure to global economic volatility and climate change regulations may impact compliance costs and project timelines.